Education
About Us
Working with TipRanks
Follow Us
DENTSPLY SIRONA Inc (XRAY)
NASDAQ:XRAY
XRAY Stock Chart & Stats
$11.29
-$0.04(-0.21%)
At close: 4:00 PM EST
$11.29
-$0.04(-0.21%)
Day’s Range― - ―
52-Week Range$9.85 - $20.60
Previous CloseN/A
Volume461.38K
Average Volume (3M)3.75M
Market Cap
$2.25B
Enterprise Value$4.65B
Total Cash (Recent Filing)$363.00M
Total Debt (Recent Filing)$2.48B
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Feb 26, 2026EPS Estimate
0.3Last Dividend Ex-Date
Sep 26, 2025Dividend Yield5.67%
Share Statistics
EPS (TTM)0.37
Shares Outstanding199,551,970
10 Day Avg. Volume4,078,962
30 Day Avg. Volume3,749,902
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.99
Price to Sales (P/S)1.02
P/FCF Ratio13.73
Enterprise Value/Market Cap2.06
Enterprise Value/Revenue1.28
Enterprise Value/Gross Profit2.52
Enterprise Value/Ebitda-10.76
Forecast
1Y Price Target
$13.42Price Target Upside18.87% Upside
Rating ConsensusHold
Number of Analyst Covering15
EPS Forecast (FY)1.65
Revenue Forecast (FY)$3.65B
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAdjusted operating margin is projected to improve by 160 basis points compared to the same period a year ago.
Leadership And StrategyThe company appointed Aldo Denti as CCO in October, who formerly held leadership roles in various divisions of J&J and is expected to be a key ingredient to the company’s future execution.
Product InnovationDentsply Sirona is focusing on new leadership and product innovation to regain its market position, with initiatives like Primescan 2 and DS Core seen as critical to the company's turnaround.
Bears Say
Earnings And GuidanceQ3 results fell short with adjusted EPS of $0.37, missing the estimate of $0.45 due to a soft gross margin and higher-than-anticipated operating expenses.
Leadership ChangesThe company also announced Matt Garth, CFO of five months, has left the company, which was attributed to a poor fit with the leadership team.
Market And Revenue ChallengesThere is a continued overhang on the general dental market with no expectation of change for the remainder of 2025, which may impact Dentsply Sirona's performance.
DENTSPLY SIRONA News
XRAY FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest stock price was $9.85 and its highest was $20.59 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is $2.25B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Feb 26, 2026 which is in 88 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Nov 06, 2025. The company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.448 by -$0.078.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 5.67%. See more information on DENTSPLY SIRONA Inc dividends here
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 0.3.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 199,551,970 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of $0.37 in its last earnings report, missing expectations of $0.448. Following the earnings report the stock price went down -12.678%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in XRAY
DENTSPLY SIRONA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$13.42 (18.87% Upside)
$13.42 (18.87% Upside)
Blogger Sentiment
Bullish
XRAY Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $100.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.65%
12-Months-Change
Fundamentals
Return on Equity
-44.44%
Trailing 12-Months
Asset Growth
-14.68%
Trailing 12-Months
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
XRAY Company Deck
XRAY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
The earnings call highlighted significant challenges, including a decline in global and U.S. sales, an impairment charge, and a drop in EPS. While there were positive aspects such as growth in European sales and Wellspect Healthcare, these were overshadowed by the broader financial difficulties and strategic challenges. The sentiment is more negative due to the pressing issues and the focus on a turnaround strategy.View all XRAY earnings summariesXRAY Net sales Breakdown
38.33% Essential Dental Solutions
17.77% Implants & Prosthetics
14.58% Equipment & Instruments
13.42% CAD/CAM
15.90% Other
XRAY Stock 12 Month Forecast
Average Price Target
$13.42
▲(18.87% Upside)
Technical Analysis
Ownership Overview
0.52% Insiders
34.12% Mutual Funds
31.42% Other Institutional Investors
13.52% Public Companies and
Individual Investors